Identification of New Prognostic Factors of Pulmonary Hypertension

被引:44
作者
Miura, Yutaka [1 ]
Fukumoto, Yoshihiro [1 ]
Sugimura, Koichiro [1 ]
Oikawa, Minako [1 ]
Nakano, Makoto [1 ]
Tatebe, Shunsuke [1 ]
Miyamichi, Saori [1 ]
Satoh, Kimio [1 ]
Shimokawa, Hiroaki [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
Cardiac index; Prognosis; Pulmonary hypertension; Thyroid dysfunction; RHO-KINASE INHIBITOR; ARTERIAL-HYPERTENSION; COMBINATION THERAPY; THYROID-DISEASE; EPOPROSTENOL; SILDENAFIL; BOSENTAN; HEMODYNAMICS; PROSTACYCLIN; MORTALITY;
D O I
10.1253/circj.CJ-10-0270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary hypertension (PH) still remains a serious disease, for which the plasma level of brain natriuretic peptide (BNP) and hemodynamic variables (eg, cardiac index Cl) are established prognostic factors The aim of the present study was to identify new additional prognostic factors of the disorder to improve the management of PH Methods and Results: The study cohort comprised 136 consecutive PH patients admitted to hospital from 1974 to 2008, all of whom were closely followed every 6-12 months During the follow-up period of 53 5 +/- 4 5 [SEM] months, 47 patients died of cardiopulmonary causes The patients who were initially treated with monotherapy showed improved pulmonary hemodynamics when subsequently treated with combination therapy Multivariate analysis showed that BNP and Cl were significant and independent prognostic factors in all PH patients. However, in PH patients with low Cl at diagnosis, only Cl improvement by PH therapy was a significant and independent prognostic factor Indeed, the patients with low CI at diagnosis (Cl <2 5) followed by subsequent normalization in response to therapy (Cl >= 2.5) showed a significantly better survival compared with those without such normalization Conclusions: Cl normalization in response to treatment is an independent new prognostic factor of PH in patients with low Cl at diagnosis, suggesting the importance of intensive therapy to achieve Cl normalization (Circ J 2010, 74: 1965-1971)
引用
收藏
页码:1965 / 1971
页数:7
相关论文
共 41 条
  • [1] Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats
    Abe, K
    Shimokawa, H
    Morikawa, K
    Uwatoku, T
    Oi, K
    Matsumoto, Y
    Hattori, T
    Nakashima, Y
    Kaibuchi, K
    Sueishi, K
    Takeshita, A
    [J]. CIRCULATION RESEARCH, 2004, 94 (03) : 385 - 393
  • [2] Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice
    Abe, Kohtaro
    Tawara, Shunsuke
    Oi, Keiji
    Hizume, Takatoshi
    Uwatoku, Toyokazu
    Fukumoto, Yoshihiro
    Kaibuchi, Kozo
    Shimokawa, Hiroaki
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 48 (06) : 280 - 285
  • [3] Diagnosis and Assessment of Pulmonary Arterial Hypertension
    Badesch, David B.
    Champion, Hunter C.
    Gomez Sanchez, Miguel Angel
    Hoeper, Marius M.
    Loyd, James E.
    Manes, Alessandra
    McGoon, Michael
    Naeije, Robert
    Olschewski, Horst
    Oudiz, Ronald J.
    Torbicki, Adam
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (01) : S55 - S66
  • [4] Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension
    Barst, Robyn J.
    Gibbs, J. Simon R.
    Ghofrani, Hossein A.
    Hoeper, Marius M.
    McLaughlin, Vallerie V.
    Rubin, Lewis J.
    Sitbon, Olivier
    Tapson, Victor F.
    Galie, Nazzareno
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (01) : S78 - S84
  • [5] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY
    DALONZO, GE
    BARST, RJ
    AYRES, SM
    BERGOFSKY, EH
    BRUNDAGE, BH
    DETRE, KM
    FISHMAN, AP
    GOLDRING, RM
    GROVES, BM
    KERNIS, JT
    LEVY, PS
    PIETRA, GG
    REID, LM
    REEVES, JT
    RICH, S
    VREIM, CE
    WILLIAMS, GW
    WU, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) : 343 - 349
  • [6] Thyroid hormone and blood pressure regulation
    Danzi, S
    Klein, I
    [J]. CURRENT HYPERTENSION REPORTS, 2003, 5 (06) : 513 - 520
  • [7] Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension
    Dimopoulos, Konstantinos
    Inuzuka, Ryo
    Goletto, Sara
    Giannakoulas, Georgios
    Swan, Lorna
    Wort, Stephen J.
    Gatzoulis, Michael A.
    [J]. CIRCULATION, 2010, 121 (01) : 20 - 25
  • [8] Evidence for Rho-Kinase Activation in Patients With Pulmonary Arterial Hypertension
    Do E, Zhulanqiqige
    Fukumoto, Yoshihiro
    Takaki, Aya
    Tawara, Shunsuke
    Ohashi, Junko
    Nakano, Makoto
    Tada, Tomohiro
    Saji, Kenya
    Sugimura, Kohichiro
    Fujita, Hiroshi
    Hoshikawa, Yasushi
    Nawata, Jun
    Kondo, Takashi
    Shimokawa, Hiroaki
    [J]. CIRCULATION JOURNAL, 2009, 73 (09) : 1731 - 1739
  • [9] Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension
    Fukumoto, Y
    Matoba, T
    Ito, A
    Tanaka, H
    Kishi, T
    Hayashidani, S
    Abe, K
    Takeshita, A
    Shimokawa, H
    [J]. HEART, 2005, 91 (03) : 391 - 392
  • [10] Recent progress in the treatment of pulmonary arterial hypertension: Expectation for Rho-kinase inhibitors
    Fukumoto, Yoshihiro
    Tawara, Shunsuke
    Shimokawa, Hiroaki
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 211 (04) : 309 - 320